Atricure Inc (ATRC) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Atricure Inc   (NASDAQ: ATRC)


Atricure Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Atricure Inc 's ROA in the second quarter of 2026?
Atricure Inc achieved a return on average assets (ROA) of 1.62 % in its second quarter of 2026, this is above ATRC's average return on assets of -8.58%.
Atricure Inc assets over the 12 months ending in its second quarter of 2026 are valued at $651 million

ROA has improved compared to -0.73% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 196 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2629, from total ROA ranking in the first quarter of 2026 at 3183.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 12.35 % 9.78 % 7.94 % 3.21 % 1.25 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 11 -5 -11 -29 -36
Return On Assets (TTM) 1.62 % -0.73 % -1.85 % -4.75 % -6.05 %
ATRC's Total Ranking # 2629 # 3183 # 3020 # 3091 # 3156
Total Assets (TTM) in million 677 644 654 630 602
Seq. Total Assets Change 5.07 % -1.56 % 3.83 % 4.61 % 2.67 %
Seq. Net Income Change 8191.67 % -93.85 % - - -

ATRC's 5 Years Annual ROA >> Back to ATRC Management Effectiveness >> Compare ATRC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 61
Sector # 197
Overall # 1919

Return On Assets Statistics
High Average Low
8.89 %
-8.58 %
-21.71 %
(Jun 30 2022)   (Dec 31 2012)



  News about Atricure Inc Return on Assets ROA

AtriCures European Beat Innovating Through Financial Challenges in Healthcare,

AtriCure s Innovative Leap: Navigating Financial Challenges with European CE Certification MASON, Ohio In a remarkable stride forward, AtriCure, Inc. (Nasdaq: ATRC), a trailblazing innovator in the realm of surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and postoperative pain management, has announced a significant regulatory achievement. The company has secured CE marking approval for the sale of its EnCompass clamp across European Union nations a noteworthy milestone in enhancing the treatment landscape for cardiovascular diseases across the continent.The CE marking, indicative of rigorous European health, safety, and environmental protection standards, opens the gateway for European surgeons to harness the advanced capabilities of the EnCompass clamp. This device is poised to revolutionize clinical procedures and patient outcomes, providing much-needed tools for more efficient surgical interventions.



Financial Statements
Atricure Inc 's Assets $ 677 million ATRC's Balance sheet
Atricure Inc 's Income $ 9 million Quarterly ATRC's Income Statement
ATRC's Income by Division See ATRC's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 7.94 % -0.81 % 4.65 % -4.79 % -14.18 %
Total Assets in million 654 606 611 584 613
Y / Y Net Income Change - - - - -
Net Income in million -11 -45 -30 -46 50
Annual Return On Assets -1.75 % -7.38 % -4.98 % -7.96 % 8.19 %

ATRC's 5 Years Annual ROA >> Back to ATRC Management Effectiveness >> Compare ATRC ROA to its Competitors



More Return On Assets Ratios
ATRC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ATRC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ATRC's Competitors
Subscribers only: Roa for Atricure Inc 's Suppliers
Subscribers only: Return On Assets for ATRC's Customers

You may also want to know
ATRC's Roi ATRC's Inventory Turnover Ratio ATRC's Growth Rates ATRC's Dividend Comparisons
ATRC's Profitability Ratios ATRC's Asset Turnover Ratio ATRC's Dividend Growth
ATRC's Roe ATRC's Valuation Ratios ATRC's Financial Strength Ratios ATRC's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Nrc Health  4.31 %
Cadre Holdings inc   4.29 %
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %

Date modified: 2026-07-28T05:32:21+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.